Skip to content

Health Condition of Cannabis Consumers in the Canadian Population

Health Condition of Cannabis Consumers in the Canadian Population: A Population-based Observational Cohort Study

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03987347
Enrollment
0
Registered
2019-06-17
Start date
2020-12-01
Completion date
2020-12-01
Last updated
2020-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cannabis Use, Health Risk, Old Age

Brief summary

This study evaluates the health condition and its evolution with time of Cannabis consumers in the Canadian population.

Detailed description

In Canada, legalization of recreational use is likely to have decreased the perception of risks associated with Cannabis use, and means that the reported adverse effects of Cannabis are not so important, suggesting that Cannabis may be useful for their illness as an alternative or complementary therapeutic. More Canadian physicians prescribed Cannabis for their patients. Both Recreational and medical use of Cannabis increase and will continue to grow up in the next coming years. Regardless, the typology of Cannabis use, more information on the health condition of Cannabis consumers may be helpful for the medical prescription of Cannabis, in particular in older adults who are more at risk of side effects.

Interventions

OTHERObservational

People who are enrolled in the Canadian Longitudinal Study on Aging. Participants undergo repeated waves of the same standardized data collection every three years. All participants are also contacted by telephone 18 months after baseline assessment to complete the Maintaining Contact Questionnaire.

Sponsors

Jewish General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Living in Canada the last 20 years * Being 60 years and over * Being consumer of cannabis

Exclusion criteria

* Living outside Canada the last 20 years * Have never consumed cannabis

Design outcomes

Primary

MeasureTime frameDescription
Neurocognitive disorderaround 20 yearsThe decrease of cognitive function changes the activities of daily living to older adults. Instrumental Activities of Daily Living Scale ( IADLs) will be used to assess independent living skills to people who are a diagnosis of mild cognitive impairment. A summary score range from 0 ( low function, dependent) to 8 ( high function, independent) will be given to each participant based on their daily activities.

Secondary

MeasureTime frameDescription
Depressionaround 20 yearsIt will be used the Centre for Epidemiologic Studies-Depression Scale (CES-D) that rates how often over the past week people experience symptoms that are associated with depression. In scoring the Center for Epidemiologic Studies Depression Scale, a value of 0,1,2,3 is assigned to a response based on the emotional feelings that the participants have.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026